Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor. 1987

J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner

Nine patients with the acquired immunodeficiency syndrome (AIDS) were administered four doses of pooled transfer factor obtained from the lymphocytes of three healthy controls and three homosexuals with stable lymphadenopathy and serum antibody to the human immunodeficiency virus. Before receiving transfer factor, all patients exhibited anergy to skin test antigens. After four weeks of transfer factor therapy, six of seven patients tested had at least one skin test response. Lymphocyte blastogenic responses to phytohemagglutinin rose from a stimulation index of 6.77 +/- 1.31 before treatment to 19.77 +/- 6.24 after four weeks of transfer factor therapy. Smaller but significant increases were also seen in blastogenic responses to antigens. Improvements in immune responses diminished after administration of transfer factor was halted. Thus, administration of transfer factor to patients with AIDS resulted in partial immune reconstitution. Further studies are indicated to examine the clinical efficacy of this immune response modifier in the treatment of AIDS.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
January 1990, Acta leprologica,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
May 1976, Blut,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
December 1977, The Tokushima journal of experimental medicine,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
June 1973, Journal of surgical oncology,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
February 1987, Transplantation proceedings,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
March 1977, Clinical and experimental immunology,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
January 2006, Tuberkuloz ve toraks,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
January 1979, Surgical forum,
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
January 2003, Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
J T Carey, and M M Lederman, and Z Toossi, and K Edmonds, and S Hodder, and L H Calabrese, and M R Proffitt, and C E Johnson, and J J Ellner
June 1982, Arthritis and rheumatism,
Copied contents to your clipboard!